Paramount Global Market Cap

ABL Bio has a market cap or net worth of 4.04 trillion as of August 8, 2025. Its market cap has increased by 204.95% in one year.

Market Cap

4.04T

Enterprise Value

3.98T

Revenue

27.63B

Ranking

n/a

PE Ratio

n/a

Stock Price

$74,500.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 4.04T, an increase of 564.46%. That is a compound annual growth rate of 33.01%.

Market Cap History

Date	Market Cap	% Change
Aug 7, 2025	4,044.01B	180.13%
Dec 30, 2024	1,443.63B	22.53%
Dec 28, 2023	1,178.16B	7.19%
Dec 29, 2022	1,099.13B	5.54%
Dec 30, 2021	1,041.42B	-27.59%
Dec 30, 2020	1,438.26B	31.46%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 19, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.80T
Celltrion	39.20T
ALTEOGEN	23.73T
SK Biopharmaceuticals	8,724.10B
Yuhan	8,599.10B
Peptron	6,872.72B
HLB Co., Ltd.	6,237.58B
PharmaResearch	5,859.76B

Market Cap Rankings